Contribution
My Lords, I fully recognise the importance of high-quality data and the need for healthcare services to learn from outcomes and continuously improve patient safety—and, of course, for women to have access to accurate information. Indeed, better data collection in women’s health is something I strongly support. I am grateful to my noble friend Lord Moylan for his introduction and explanation of the Bill. However, I remain unconvinced that the Bill is the right way to achieve those outcomes. As the House of Lords Library briefing notes, abortion complications are already recorded, abortion statistics are already published annually, and there is already a statutory framework requiring notification and reporting of relevant information. The question before us is not whether data should be collected but whether abortion alone should be singled out in primary legislation for a dedicated annual report.
When we last debated the Bill in December 2024, the Minister argued that abortion is a safe procedure and no other area of healthcare has a legislative requirement of this kind for the publication of complication reports. As we have heard, the evidence before us continues to show that abortion is a very safe procedure and complications are rare, as set out in the briefing from the Royal College of Obstetricians and Gynaecologists. That briefing also warns that the Bill risks stigmatising both women accessing abortion care and the healthcare professionals who provide it. The college further argues that decisions around clinical practice and patient safety should be led by medical evidence and clinical expertise, rather than through primary legislation.
Developments since our previous debate have strengthened rather than weakened the case against the Bill. The House of Lords Library briefing highlights that the Office for Statistics Regulation completed a compliance review of abortion statistics in April 2026 and concluded that the statistics continued to meet the standards required under the code of practice for statistics. The review found that the existing data source was suitable for producing the statistics, and the limitations of complications data were adequately explained.
If the independent regulator responsible for assuring statistical quality has reviewed the system and confirmed that the statistics remain fit for purpose, it is difficult to see the case for legislating for a new reporting requirement before ongoing improvement work has been completed. I am grateful to the noble Baroness, Lady Freeman, for sharing her experience on complications. There is also a practical problem. The Bill would require annual reporting that combines data sources that are not currently capable of providing the information in the format that the Bill demands.
I would like to discuss this in the wider context of the Health Bill currently before Parliament, as other speakers have, and the Government’s plan for a single patient record. There remains genuine potential here to improve health data across the NHS, including women’s reproductive health data, but these reforms are still being developed and will be implemented over a number of years. As the noble Baroness, Lady Thornton, highlighted, stakeholders have rightly raised concerns that any future data-sharing arrangements must preserve confidentiality, particularly for women seeking sexual and reproductive health care. For many women, confidentiality is fundamental to their ability to access care safely, and that is particularly true of women experiencing domestic abuse, coercive control or honour-based abuse. I look forward to the debate on those amendments next week.
While I fully agree that we should strive for improved data, a better route is through the broader reforms already under way. I would be grateful if the Minister, in her response, could outline what steps the Government are taking to improve the quality and interoperability of women’s health data, so that policymakers and clinicians can access the information they need. Good data matters, patient safety matters, and women’s health matters, but those objectives are best served through proportionate, evidence-based improvements across the healthcare system, not through primary legislation that singles out one lawful medical procedure. For those reasons, while I respect the intentions behind the Bill, I am not persuaded that it is necessary or that it would improve outcomes for women.